The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Overall survival after the introduction of adjuvant treatment in stage III melanoma: A nationwide registry based study.
 
Hildur Helgadottir
No Relationships to Disclose
 
Lars Ny
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Pierre Fabre; Sanofi; Zealth
Speakers' Bureau - Bristol-Myers Squibb/Celgene; GlaxoSmithKline; LEO Pharma; MSD; Novartis; Pfizer
Research Funding - MSD (Inst); Syndax (Inst)
 
Gustav J. Ullenhag
Stock and Other Ownership Interests - Essity
Honoraria - Bristol-Myers Squibb/Medarex; MSD Oncology; Novartis; Pierre Fabre
Consulting or Advisory Role - Alligator Bioscience; Bristol-Myers Squibb/Medarex; Incyte; LIDDS; MSD Oncology; Novartis; Sanofi; SeqCure Immunology
Research Funding - Alligator Bioscience; Lokon Pharma
 
Johan Falkenius
No Relationships to Disclose
 
Rasmus Mikiver
No Relationships to Disclose
 
Roger Olofsson Bagge
Stock and Other Ownership Interests - SATMEG Ventures
Consulting or Advisory Role - BD Bard; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche; Sanofi
Speakers' Bureau - Roche
Research Funding - BMS (Inst); Endomagnetics; Skyline Diagnostics (Inst)
 
Karolin Isaksson
No Relationships to Disclose